Angiodynamics (ANGO) Receivables (2011 - 2026)
Angiodynamics' (ANGO) quarterly Receivables came in at $48.3 million in Q2 2026, up 12.67% YoY from $42.9 million in Q2 2025, and up 6.09% on a QoQ basis from $45.6 million in Q1 2026.
Angiodynamics (ANGO) Receivables (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Receivables data on file, last reported at $48.3 million in Q2 2026.
- Quarterly Receivables rose 12.67% year-over-year to $48.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $48.3 million (up 12.67% YoY) and the FY2026 annual result came in at $48.3 million, up 12.67% from the prior year.
- Receivables grew to $48.3 million in Q2 2026, from $45.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $53.6 million in Q3 2022 to a low of $39.6 million in Q3 2024.
- A 5-year average of $47.2 million and a median of $46.9 million in 2026 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables soared 51.3% — and 2024, when it fell 20.48%.
- Tracing ANGO's Receivables over 5 years: stood at $52.9 million in 2022, then dropped by 2.36% to $51.6 million in 2023, then fell by 16.37% to $43.2 million in 2024, then advanced by 2.96% to $44.4 million in 2025, then rose by 8.76% to $48.3 million in 2026.
- The last three Receivables figures came in at $48.3 million (Q2 2026), $45.6 million (Q1 2026), and $44.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.46 Bn | 1.96 Bn | 1.67 Bn |
| 2 | Becton Dickinson | 52.27 Bn | 51.41 Bn | 2.32 Bn | 2.36 Bn |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn | 2.08 Bn |
| 4 | Resmed | 33.83 Bn | 32.36 Bn | 861.22 Mn | 1.08 Bn |
| 5 | Medline | 28.80 Bn | 26.13 Bn | 2.22 Bn | 3.66 Bn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 712.00 Mn |
| 7 | Solventum | 15.33 Bn | 14.93 Bn | 1.29 Bn | 1.43 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 809.20 Mn |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 1.92 Bn |
| 10 | Angiodynamics | 653.00 Mn | 599.13 Mn | 46.77 Mn | 48.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 48.33 Mn |
| Feb 28, 2026 | 45.55 Mn |
| Nov 30, 2025 | 44.43 Mn |
| Aug 31, 2025 | 42.64 Mn |
| May 31, 2025 | 42.89 Mn |
| Feb 28, 2025 | 43.47 Mn |
| Nov 30, 2024 | 43.16 Mn |
| Aug 31, 2024 | 39.56 Mn |
| May 31, 2024 | 43.61 Mn |
| Feb 29, 2024 | 49.48 Mn |
| Nov 30, 2023 | 51.60 Mn |
| Aug 31, 2023 | 49.76 Mn |
| May 31, 2023 | 52.83 Mn |
| Feb 28, 2023 | 50.89 Mn |
| Nov 30, 2022 | 52.85 Mn |
| Aug 31, 2022 | 53.59 Mn |
| May 31, 2022 | 52.30 Mn |
| Feb 28, 2022 | 41.81 Mn |
| Nov 30, 2021 | 38.21 Mn |
| Aug 31, 2021 | 35.42 Mn |